Chocolate consumption in pregnancy and reduced likelihood of preeclampsia

Epidemiology

Volumn 19, Issue 3, 2008, Pages 459-464

  Triche, Elizabeth W ^a   Grosso, Laura M ^a   Belanger, Kathleen ^a   Darefsky, Amy S ^b   Benowitz, Neal L ^c   Bracken, Michael B ^a  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THEOBROMINE;

ADULT; ARTICLE; CACAO; COHORT ANALYSIS; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SELF REPORT; UMBILICAL CORD BLOOD;

ADULT; CACAO; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONNECTICUT; FEMALE; HUMANS; LOGISTIC MODELS; MASSACHUSETTS; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 42149166592     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31816a1d17     Document Type: Article

References (27)

1. Fisher ND, Hughes M, Gerhard-Herman M, et al. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens. 2003;21:2231-2234.
2. Heiss C, Kleinbongard P, Dejam A, et al. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol. 2005;46:1276-1283.
3. Song Y, Ridker PM, Manson JE, et al. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabet Care. 2005;28:1438-1444.
4. Weglicki W, Quamme G, Tucker K, et al. Potassium, magnesium, and electrolyte imbalance and complications in disease management. Clin Exp Hypertens. 2005;27:95-112.
5. Smit HJ, Gaffan EA, Rogers PJ. Methylxanthines are the psychopharmacologically active constituents of chocolate. Psychopharmacology (Berl). 2004;176:412-419.
6. Stavric B. Methylxanthines: Toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines. Chem Toxic. 1988;26:725-733.
7. Kelly CJ, Effects of theobromine should be considered in future studies. Am J Clin Nutr. 2005;82:486-7; [author reply 487-488].
8. ACOG Practice Bulletin No. 33: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99:159-167.
9. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46:1243-1249.
10. Cunningham FG, Gant NF, Leveno KJ, et al. Hypertensive disorders in pregnancy. In: Williams Obststrics, 21st ed. New York: McGraw-Hill; 2001, pp. 567-618.
11. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol. 2000;95:24-28.
12. Brown DW, Dueker N, Jamieson DJ, et al. Preeclampsia and the risk of ischemic stroke among young women: results from the stroke prevention in young women study. Stroke. 2006;37:1055-1059.
13. Forest J-C, Girouard J, Masse J, et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol. 2005;105:1373-1380.
14. Pouta A, Hartikainen A-L, Sovio U, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension. 2004;43:825-831.
15. Seely EW, Solomon CG, Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88:2393-2398.
16. Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326:7394-7845. Doi: 10.1136/bmj.326.
17. Bracken MB, Triche EW, Belanger K, et al. Association of maternal caffeine consumption with decrements in fetal growth. Am J Epidemiol. 2003;157:456-466.
18. Grosso LM, Triche EW, Belanger K, et al. Caffeine metabolites in umbilical cord blood, Cytochrome P-450 1A2 activity, and intrauterine growth restriction. Am J Epidemiol. 2006;163:1035-1041.
19. Gifford RW, August PA, Cunningham G, et al. Report on the National High Bood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.
20. Grassi D, Necozione S, Lippi C, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005;46:398-405.
21. Grassi D, Lippi C, Necozione S, et al. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr. 2005;81:611-614.
22. Fisher ND, Hollenberg NK, Aging and vascular responses to flavanol-rich cocoa. J Hypertens. 2006;24:1575-1580.
23. Taubert D, Roesen R, Schomig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med. 2007;167:626-634.
24. Rodopoulos N, Hojvall L, Norman A. Elimination of theobromine metabolites in healthy adults. Scand J Clin Lab Invest. 1996;56:373-383.
25. Grosso LM, Bracken MB, Caffeine metabolism, genetics, and perinatal outcomes: A review of exposure assessment considerations during pregnancy. Ann Epidemiol. 2005;15:460-466.
26. Many A, Westerhausen-Larson A, Kanbour-Shakir A, et al. Xanthine oxidase/dehydrogenase is present in human placenta. Placenta. 1996;17:361-365.
27. Bracken MB. Cotinine and spontaneous abortion: might variations in metabolism play a role? Epidemiology. 2006;17:492-494.